The business generated a turnover of ₹113.5 crore in 2024-25 with an EBITDA of ₹28.9 crore. It has around 470 people strong field force and more than 1,600 stockists and other distribution related infrastructure.
Aurobindo Pharma arm acquires non-oncology portfolio of Khandelwal Labs
Published 1 hour ago
Source: thehindu.com
Categories
Business
Related Articles from thehindu.com
13 minutes ago
Government planning further electricity tariff reductions in A.P., says Minister
16 minutes ago
Don’t need treaty with Dhaka to push back illegal immigrants: Himanta
17 minutes ago
Israel says forces open fire on West Bank stone-throwers, one dead
20 minutes ago
Two students killed in motorcycle crash at Narsingi
20 minutes ago
Explained: Why are government school teachers protesting in Tamil Nadu
22 minutes ago